WWM
ESPR icon

WT Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

WT Wealth Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,100
Closed -$26.8K – 139
2025
Q3 		$26.8K Hold
10,100
– – 0.01% 139
2025
Q2 		$9.94K Hold
10,100
– – ﹤0.01% 147
2025
Q1 		$14.5K Hold
10,100
– – ﹤0.01% 124
2024
Q4 		$22.2K Hold
10,100
– – 0.01% 134
2024
Q3 		$20.6K Hold
10,100
– – 0.01% 129
2024
Q2 		$22.4K Hold
10,100
– – 0.01% 121
2024
Q1 		$27.1K Hold
10,100
– – 0.01% 111
2023
Q4 		$30.2K Hold
10,100
– – 0.01% 108
2023
Q3 		$9.9K Buy
+10,100
New +$14.6K ﹤0.01% 104

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return